HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells
- PMID: 12377730
- DOI: 10.1161/01.atv.0000034707.40046.02
HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells
Abstract
Objective: Although HIV protease inhibitors have been successfully used against HIV infection, many metabolic side effects and premature cardiovascular diseases are often associated with this therapy. The mechanisms of these complications are not clear. In this study, we investigated the effect of the HIV protease inhibitor ritonavir on human endothelial cell cultures.
Methods and results: By using nonradioactive cell proliferation and cytotoxicity assays, human endothelial cells treated with ritonavir showed a significant decrease in cell viability and an increase in cytotoxicity in a time- and dose-dependent fashion. Mitochondrial DNA was also substantially damaged with ritonavir treatment by long polymerase chain reaction analysis. In contrast, ritonavir had a very limited effect on endothelial apoptosis, as assessed by analyses of DNA fragmentation and cellular caspase-3 activity.
Conclusions: These data demonstrate, for the first time, that the HIV protease inhibitor ritonavir at concentrations near clinical plasma levels is able to directly cause endothelial mitochondrial DNA damage and cell death mainly through necrosis pathways but not through apoptosis. This study suggests that HIV protease inhibitor-mediated endothelial injury may contribute to its cardiovascular complications.
Comment in
-
HIV therapies and atherosclerosis: answers or questions?Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1758-60. doi: 10.1161/01.atv.0000042080.46554.e6. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426201 Review. No abstract available.
Similar articles
-
Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma.Blood. 2002 May 15;99(10):3771-9. doi: 10.1182/blood.v99.10.3771. Blood. 2002. PMID: 11986235
-
The HIV protease inhibitor ritonavir synergizes with butyrate for induction of apoptotic cell death and mediates expression of heme oxygenase-1 in DLD-1 colon carcinoma cells.Br J Pharmacol. 2004 Dec;143(7):890-8. doi: 10.1038/sj.bjp.0706023. Epub 2004 Oct 25. Br J Pharmacol. 2004. PMID: 15504750 Free PMC article.
-
Nordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries.Med Sci Monit. 2011 Nov;17(11):BR312-318. doi: 10.12659/msm.882040. Med Sci Monit. 2011. PMID: 22037733 Free PMC article.
-
Atazanavir/ritonavir: a review of its use in HIV therapy.Drugs Today (Barc). 2008 Feb;44(2):103-32. doi: 10.1358/dot.2008.44.2.1137107. Drugs Today (Barc). 2008. PMID: 18389089 Review.
-
Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.Drugs. 2005;65(5):633-59. doi: 10.2165/00003495-200565050-00005. Drugs. 2005. PMID: 15748098 Review.
Cited by
-
Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV.Case Rep Vasc Med. 2015;2015:157623. doi: 10.1155/2015/157623. Epub 2015 Jan 18. Case Rep Vasc Med. 2015. PMID: 25685591 Free PMC article.
-
Heme oxygenase-1-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunction.Free Radic Biol Med. 2016 May;94:218-29. doi: 10.1016/j.freeradbiomed.2016.03.003. Epub 2016 Mar 8. Free Radic Biol Med. 2016. PMID: 26968795 Free PMC article.
-
In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells.Antimicrob Agents Chemother. 2006 Nov;50(11):3824-32. doi: 10.1128/AAC.00437-06. Epub 2006 Aug 28. Antimicrob Agents Chemother. 2006. PMID: 16940060 Free PMC article.
-
Angiogenesis, Lymphangiogenesis, and the Immune Response in South African Preeclamptic Women Receiving HAART.Int J Mol Sci. 2019 Jul 30;20(15):3728. doi: 10.3390/ijms20153728. Int J Mol Sci. 2019. PMID: 31366152 Free PMC article. Review.
-
Premature and accelerated aging: HIV or HAART?Front Genet. 2013 Jan 28;3:328. doi: 10.3389/fgene.2012.00328. eCollection 2012. Front Genet. 2013. PMID: 23372574 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials